AMGN Technical Analysis



As of date:2/13/2025
AMGN stock price:296.97
AMGN 50 DMA:274.70
AMGN 200 DMA:303.18
AMGN MACD (200-50):28.48
AMGN RSI:68.39
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)68.39
Extremely
Oversold

Also see:
AMGN Market Cap History
AMGN Shares Outstanding History
AMGN YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree AMGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

UEC Crosses Below Key Moving Average Level
30 minutes ago


DRS Makes Notable Cross Below Critical Moving Average
31 minutes ago


RGC Resources (RGCO) Shares Cross Below 200 DMA
31 minutes ago


Notable Two Hundred Day Moving Average Cross - DY
33 minutes ago


Notable Two Hundred Day Moving Average Cross - WKC
33 minutes ago


ZTR Crosses Below Key Moving Average Level
36 minutes ago


Nexa Resources (NEXA) Shares Enter Oversold Territory
36 minutes ago


LSAK Crosses Above Key Moving Average Level
39 minutes ago


ORN Crosses Below Key Moving Average Level
42 minutes ago


ALLY Crosses Above Key Moving Average Level
42 minutes ago


JKS Crosses Above Key Moving Average Level
44 minutes ago


Acushnet Holdings (GOLF) Shares Cross Below 200 DMA
44 minutes ago


Cadre Holdings (CDRE) Shares Cross Below 200 DMA
45 minutes ago


EMBC Makes Notable Cross Below Critical Moving Average
4 hours, 32 minutes ago


PDD Makes Bullish Cross Above Critical Moving Average
5 hours, 1 minute ago


More Technical Analysis News

AMGN Technical AnalysisAMGN RSI
Amgen Inc. is a biotechnology company dedicated to discovering, developing, manufacturing, and delivering human therapeutics. It focuses on addressing high unmet medical needs to enhance health outcomes and improve lives. Operating primarily in the human therapeutics segment, Amgen's extensive portfolio includes well-known products such as Aranesp, ENBREL, Prolia, Neulasta, Otezla, and Repatha, among others. These therapies target various conditions, showcasing Amgen's commitment to leveraging its expertise in biotechnology to provide innovative solutions for patients.

When researching a stock like Amgen, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from AMGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for AMGN stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
AMGN DMAAMGN MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amgen (AMGN) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
BMY Technical Analysis
BSX Technical Analysis
CAH Technical Analysis
CI Technical Analysis
CNC Technical Analysis
COO Technical Analysis
COR Technical Analysis
More Healthcare companies »

 

AMGN Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2025, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.